Vitaresp-FX 30mg Syrup 30 ml

babies: it is safe for children if prescribed by a doctor. pregnancy: not applicable. lactating mother: not applicable. alcohol: not applicable. driving: not applicable. kidney: use this medication with caution. dose adjustment is necessary for kidney disease patients. liver: this medication is safe to use in liver disease patients.
even though dose adjustment is not necessary for liver disease patients, consult your doctor..

Nausea Vomiting Diarrhoea Dizziness Headache Body pain Skin rash.

montelukast in VITARESP FX is a leukotriene receptor antagonist class of medication. it works by stopping the action of leukotriene (inflammatory chemical) in the lungs, reducing inflammation and relaxation of smooth muscle.
fexofenadine is an antihistamine class of medication. it acts by stopping the release of histamine that results in allergic signs..

If you miss a dose, take VITARESP FX as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• VITARESP FX tablet is an antihistamine & leukotriene receptor antagonistic agent used to treat allergic symptoms • it can be taken with or without food • inform your doctor if you are taking any other medications • avoid tasks that require concentrations as this medication may alter alertness • avoid taking alcohol while taking this medication as it may increase sleepiness • take this medication as prescribed by your doctor • don’t stop this medication unless told by your doctor • drink plenty of fluids while taking this medication as it may cause dehydration.

• gemfibrozil + montelukast: concurrent use of this medication may result in an increased level of montelukast plasma concentrations • dasabuvir + montelukast: concurrent use of this medication may result in an increased concentration of dasabuvir • phenobarbital + montelukast: concurrent use of this medication may result in decreased availability of montelukast • rifampin + montelukast: concurrent use of this medication may result in decreased availability of montelukast • magnesium carbonate + fexofenadine: concurrent use of this medication may result in decreased effects of fexofenadine • rifampin + fexofenadine: concurrent use of this medication may result in decreased effects of fexofenadine • voclosporin + fexofenadine: concurrent use of this medication may result in an increase blood levels and effects of fexofenadine.